Researchers have found a small subset of antibodies that target a site at the base of the influenza virus hemagglutinin protein.
List view / Grid view
University of Chicago
The new nanoparticle uses a peptide to target the vascular cell adhesion molecule 1 and reduced the size of vascular lesions in a mouse study.
Scientists from the University of Chicago discovered that the drug masitinib inhibits the replication of SARS-CoV-2 in mice.
Research shows that cells gather more data inside the thalamus than once believed, potentially changing medicines for brain disorders.
Scientists have used imaging methods and machine learning to understand cellular metabolism at the single-cell level.
Antibodies produced by B cells against the H1N1 influenza virus can also neutralise other strains, which could be used to developed vaccines.
Using exclusively male animals in experiments biases results, argues Rebecca Shansky.
A 3D map of genetic interactions in CVD could aid researchers investigating future treatments for heat attacks, heart failure and heart rhythm disorders.
The structure of teneurins, proteins involved in embryonic development and the nervous system, is more like bacterial toxins than any other human protein.
Researchers from the University of Chicago have uncovered the mechanism by which small RNA molecules (piRNAs) locate and silence foreign invading genes, whilst avoiding ‘self’ genes.
25 May 2016 | By Victoria White, Digital Content Producer
TwoXAR is to collaborate with the Department of Medicine at the University of Chicago to identify potential new medicines for treating atherosclerosis...